Building the investment case for asthma R&D: the European Asthma Research and Innovation Partnership argument

Affiliations

• ¹ Research & Policy, European Asthma Research & Innovation Partnership, Asthma UK, London, UK.
• ² Swiss Institute of Allergy and Asthma Research (SIAF), Medical Faculty, University of Zurich, Zurich, Switzerland.
• ³ Asthma and Allergy Research, IMM Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
• ⁴ Department of Medicine, Southampton NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, UK.
• ⁵ Department of Paediatrics, Paediatric Respiratory and Allergy Units, Arrixaca University Children's Hospital, University of Murcia, Murcia, Spain.
• ⁶ Department of Respiratory Medicine, Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, UK.
• ⁷ Medical University of Łódź, Łódź, Poland.
• ⁸ Respiratory Therapeutic Area, Respiratory Franchise, Novartis Pharmaceuticals, East Hanover, NJ, USA.
• ⁹ Asthma Clinical Discovery, Respiratory Therapy Area Unit, GlaxoSmithKline, Hertfordshire, UK.
• ¹⁰ European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.
• ¹¹ Allergy Department, University of Athens, Athens, Greece.
• ¹² Allergy & Paediatric Allergy, University of Manchester, Manchester, UK.
• ¹³ European Lung Foundation, Sheffield, UK.